|
ZNF85 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.13995529366684E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68679514800374E-11 |
| Normal-vs-Stage2 |
1.68479999951288E-07 |
| Normal-vs-Stage3 |
3.42281758491936E-12 |
| Normal-vs-Stage4 |
1.64956936998806E-12 |
| Stage1-vs-Stage2 |
2.019200E-01 |
| Stage1-vs-Stage3 |
1.947770E-01 |
| Stage1-vs-Stage4 |
2.176500E-03 |
| Stage2-vs-Stage3 |
5.373800E-02 |
| Stage2-vs-Stage4 |
4.262300E-03 |
| Stage3-vs-Stage4 |
1.212170E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.10045306200846E-12 |
| Normal-vs-AfricanAmerican |
1.13210000041164E-07 |
| Normal-vs-Asian |
5.18449949638011E-10 |
| Caucasian-vs-AfricanAmerican |
8.011000E-01 |
| Caucasian-vs-Asian |
3.758200E-01 |
| AfricanAmerican-vs-Asian |
4.494600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.03329583672962E-11 |
| Normal-vs-Female |
5.98165961207542E-12 |
| Male-vs-Female |
5.453400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.32258698121768E-12 |
| Normal-vs-Age(41-60Yrs) |
4.22428758639626E-12 |
| Normal-vs-Age(61-80Yrs) |
1.37099998021029E-10 |
| Normal-vs-Age(81-100Yrs) |
7.65020000015326E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.701600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.811200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.325200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.162200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.056400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.888000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.821800E-02 |
| Classical-VS-Follicular |
6.637300E-04 |
| Classical-VS-Other |
9.304800E-01 |
| Classical-VS-Normal |
6.9967365234902E-12 |
| Tall-VS-Follicular |
1.98198999999954E-05 |
| Tall-VS-Other |
3.193200E-01 |
| Tall-VS-Normal |
1.3988810110277E-13 |
| Follicular-VS-Other |
5.818300E-02 |
| Follicular-VS-Normal |
1.5159999999792E-07 |
| Other-VS-Normal |
1.67169999998329E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.681899478167E-11 |
| Normal-vs-N1 |
4.65516514225328E-13 |
| N0-vs-N1 |
2.676000E-02 |
|
|
